Cardinal Health, US14149Y1082

Cardinal Health stock holds firm after August 11 earnings

Published on 08/21/2026 at 10:16 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Cardinal Health stock is steady after its August 11, 2026 quarter, where EPS came in at $2.91 and revenue reached $63.67 billion.

Extreme Makroaufnahme weißer Kapseln in Silberfolie-Blisterpackung mit Bokeh-Hintergrund
Makro-Detailaufnahme weißer pharmazeutischer Kapseln in Blisterfolie – Cardinal Health Inc. ISIN US14149Y1082, Illustration mit AI erstellt.

Cardinal Health Inc. stock (ISIN US14149Y1082) trades with a market cap of $54.59 billion and has stayed close to the $234 level as the company digests its August 11, 2026 quarter, which delivered $2.91 in adjusted earnings per share and $63.67 billion in revenue.

Earnings set the tone

The quarter's EPS topped the $2.42 consensus by $0.49, while revenue missed the $65.15 billion estimate by $1.48 billion, a split that kept the focus on profitability rather than top-line momentum. The same quarter last year produced $2.08 in EPS, so this year's result marked a year-over-year gain of $0.83 per share.

That gap matters for investors because the latest numbers show stronger earnings power even as growth expectations stayed demanding. The business also said FY 2027 EPS guidance stands at $12.40 to $12.60, giving the stock a fresh reference point after the report.

Insider sales add context

Recent filings and market reports also pointed to insider selling, including one transaction valued at $29.4 million and another at $8.27 million, both disclosed around August 20, 2026. The shares were quoted near $234.85 in the same period, and the one-year move was still described as 55 percent higher.

For traders, that combination of a strong quarterly EPS beat, a revenue shortfall, and insider selling creates a more balanced read than the headline numbers alone. The market is now left to decide whether the earnings run rate or the slower sales trend matters more.

Cardinal Health products

The company's distribution and pharmaceutical operations remain the core of the story, with Cardinal Health continuing to serve hospitals, pharmacies, and physician practices across the U.S. That mix leaves the earnings trajectory tied to drug distribution volumes, service contracts, and margin control rather than a single consumer product cycle.

Price and range

Cardinal Health shares were last quoted at $234.73 and the stock's 52-week range spanned $145.87 to $258.30. That leaves the shares in the upper half of the range after a year in which the stock was still described as 55 percent higher.

Fact box

Company: Cardinal Health Inc.
ISIN: US14149Y1082
Ticker: CAH
Exchange: NYSE
Market cap: $54.59 billion
Sector / Industry: Health Care / Healthcare Distributors
Index membership: S&P 500

Disclaimer...

en | US14149Y1082 | CARDINAL HEALTH | boerse | 69979764 | bgmi